87 related articles for article (PubMed ID: 28357671)
1. Analysis of NK Cell Function and Receptor Expression During HTLV-1 and HTLV-2 Infection.
Bozzano F; Marras F; De Maria A
Methods Mol Biol; 2017; 1582():183-194. PubMed ID: 28357671
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous proliferation of memory (CD45RO+) and naive (CD45RO-) subsets of CD4 cells and CD8 cells in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II.
Prince HE; York J; Owen SM; Lal RB
Clin Exp Immunol; 1995 Nov; 102(2):256-61. PubMed ID: 7586675
[TBL] [Abstract][Full Text] [Related]
4. Establishment of novel lymphoid cell lines dually infected with human T cell lymphotropic viruses types I and II.
Kubota T; Morishita N; Tanaka Y; Sawada T; Miyagi T; Ohtsuki Y; Miyoshi I
J Infect Dis; 1995 Jul; 172(1):220-4. PubMed ID: 7797915
[TBL] [Abstract][Full Text] [Related]
5. Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain.
Vallejo A; Loza E; Mateos ML
J Clin Virol; 2015 Mar; 64():72-3. PubMed ID: 25728082
[No Abstract] [Full Text] [Related]
6. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
Berini CA; Eirin ME; Pando MA; Biglione MM
J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
[TBL] [Abstract][Full Text] [Related]
7. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
[TBL] [Abstract][Full Text] [Related]
8. Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells.
Lo KM; Vivier E; Rochet N; Dehni G; Levine H; Haseltine WA; Anderson P
J Immunol; 1992 Dec; 149(12):4101-8. PubMed ID: 1460293
[TBL] [Abstract][Full Text] [Related]
9. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
[TBL] [Abstract][Full Text] [Related]
10. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
11. Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: addressing the issue of indeterminate HTLV results.
Waters A; Oliveira AL; Coughlan S; de Venecia C; Schor D; Leite AC; Araújo AQ; Hall WW
J Clin Virol; 2011 Sep; 52(1):38-44. PubMed ID: 21704554
[TBL] [Abstract][Full Text] [Related]
12. Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
Lal RB; Rudolph DL; Schmid DS; Lairmore MD
Clin Exp Immunol; 1992 Feb; 87(2):293-7. PubMed ID: 1370929
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
[TBL] [Abstract][Full Text] [Related]
14. Detection of antibodies to human T-cell leukemia virus types 1 and 2 in breast milk from East Asian women.
Matsubara F; Sagara Y; Kato Y; Harada K; Koizumi A; Haraguchi K
Biol Pharm Bull; 2014; 37(2):311-4. PubMed ID: 24492727
[TBL] [Abstract][Full Text] [Related]
15. Apparent ineffectiveness of natural killer cells vis-à-vis retrovirus-infected targets.
Zheng ZY; Zucker-Franklin D
J Immunol; 1992 Jun; 148(11):3679-85. PubMed ID: 1350295
[TBL] [Abstract][Full Text] [Related]
16. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis.
Bailer RT; Lazo A; Harisdangkul V; Ehrlich GD; Gray LS; Whisler RL; Blakeslee JR
J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355
[TBL] [Abstract][Full Text] [Related]
17. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
Costa JM; Segurado AC
J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
[TBL] [Abstract][Full Text] [Related]
18. Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors.
Carvalho EM; Bacellar O; Porto AF; Braga S; Galvão-Castro B; Neva F
J Acquir Immune Defic Syndr; 2001 May; 27(1):1-6. PubMed ID: 11404513
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.
McGinn TM; Wei Q; Stallworth J; Fultz PN
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):443-56. PubMed ID: 15157363
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
